Investors

Press Releases

Jul 09, 2018 8:00am EDT

iBio Establishes Strategic Commercial Relationship with CC-Pharming Ltd. of Beijing, China

Jun 26, 2018 6:59pm EDT

iBio, Inc. Closes $16,000,000 Public Offering

Jun 22, 2018 7:26am EDT

iBio, Inc. Prices $16,000,000 Public Offering

Jun 08, 2018 4:30pm EDT

iBio, Inc. Announces Completion of 1-For-10 Reverse Stock Split

Jun 08, 2018 4:01pm EDT

iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan

Jun 05, 2018 8:30am EDT

iBio and ONEWAY Diagnostica Develop New Products for Brazil

May 31, 2018 8:30am EDT

iBio, Inc. Announces Reverse Stock Split

Mar 14, 2018 8:30am EDT

iBio Selects Lead Candidate for its Fibrosis Therapeutics Program

Mar 12, 2018 8:30am EDT

iBio Patent Issues in China on Protein Glycosylation Modification

Mar 07, 2018 8:45am EST

iBio Expands Antibody Development and Production Services to Include Fc Fusion Therapeutics

Previous
1…
3
4
5
6
7
8
9
10
11
12
Next